We are looking for child to join a CD clinical trial to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or moderate to severe ulcerative colitis (including associated symptoms such as recurrent diarrhea, stomach pain, bloody stool, frequent fevers and/or canker sores), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited so act quickly.
